The BRN.AX stock trades at A$0.14 pre-market on 07 Feb 2026, down from its 50-day average of A$0.17. This early session note ties BrainChip Holdings Ltd (BRN.AX) valuation and trading signals to its Akida neuromorphic AI products and the upcoming FY26 earnings announcement on 04 Mar 2026. Investors in AI stocks should weigh high short-term volatility and low revenue per share against a model-based yearly target of A$0.166 from Meyka AI.
BRN.AX stock: Quick snapshot and market context
BrainChip Holdings Ltd (BRN.AX) is listed on the ASX and currently shows market cap A$330,184,159.00 and shares outstanding 2,358,458,279.00. The stock is trading at A$0.14 with a day range A$0.13–A$0.142 and year range A$0.13–A$0.325.
Volume is elevated at 17,169,675.00 today versus an average of 8,959,143.00, giving a relative volume of 1.90 and signalling above-normal attention among AI stocks.
BRN.AX stock: Financials, valuation and growth metrics
Key reported metrics show EPS -A$0.02 and a negative PE ratio of -7.00, reflecting ongoing losses as BrainChip scales. Price-to-book sits near 13.30, price-to-sales is ~174.50, and current ratio is 5.18, indicating a strong liquidity buffer but thin revenue per share of A$0.00063.
Revenue growth improved in FY2024 at 71.55%, while net income and EPS growth were both positive year-on-year near 15.41% and 19.92% respectively. These mixed signals mean valuation looks rich vs fundamentals, typical for small-cap AI hardware names.
BRN.AX stock: Technicals and trading signals
Technical indicators show short-term bullish bias with RSI 60.30 and ROC 15.62%, while momentum oscillators flag overbought readings (CCI 137.05, MFI 86.99). The 50-day average is A$0.1718 and the 200-day average is A$0.1974, so price sits below medium and long-term moving averages.
High intraday volume and an OBV of -123,939,536.00 suggest distribution phases. Traders should note ATR A$0.01 and Bollinger band middle at A$0.17 for short-term range expectations.
BRN.AX stock: Meyka AI grade, model forecast and price targets
Meyka AI rates BRN.AX with a score out of 100: 64.90 / 100 — Grade B — Suggestion: HOLD. This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, forecasts, and analyst consensus. These grades are informational and not financial advice.
Meyka AI’s forecast model projects a yearly price of A$0.166, which compares to the current A$0.14 and implies an upside of +18.57%. We outline price targets: base A$0.17 (+21.43%), bull A$0.30 (+114.29%), and bear A$0.08 (-42.86%). Forecasts are model-based projections and not guarantees.
BRN.AX stock: Risks and upcoming catalysts
Main near-term catalyst is the FY26 earnings announcement on 04 Mar 2026, which could move the stock materially given the thin revenue base and negative EPS. Sector headwinds for semiconductors and AI hardware adoption cycles remain risk factors.
Other risks include a high price-to-sales ratio, continued quarterly losses, and tight investor sentiment reflected in a recent external company rating of C- (Strong Sell) dated 06 Feb 2026. Positive catalysts would be meaningful Akida design wins or a clear path to recurring revenue.
BRN.AX stock: AI strategy and investor considerations
BrainChip’s Akida neuromorphic IP targets low-power edge AI in automotive, cybersecurity and vision markets. For AI stocks investors, BRN.AX offers pure-play exposure to neuromorphic processors but with high execution risk and limited near-term commercial scale.
Position sizing should reflect extreme volatility, low liquidity at times, and a long horizon to monetisation. Use stop limits and keep BRN.AX as a satellite allocation in AI-themed portfolios. For the company site and recent updates, see BrainChip and company social posts at BrainChip Twitter. For live quotes use our internal page at Meyka BRN.AX page.
Final Thoughts
BRN.AX stock trades at A$0.14 pre-market on 07 Feb 2026 with elevated volume and mixed signals across fundamentals and technicals. Meyka AI’s model projects A$0.166 over the next year, implying +18.57% upside versus current price, while a bull case to A$0.30 would double the stock. The company shows improving revenue growth but negative EPS and stretched valuation metrics such as price-to-sales ~174.50 and price-to-book ~13.30, which keep the risk profile high. The next earnings release on 04 Mar 2026 is the main short-term catalyst and could confirm commercial traction or widen losses. We view BRN.AX as a speculative AI stocks exposure best sized as a small, monitored position. Forecasts are model-based projections and not guarantees. Meyka AI provides this analysis as an AI-powered market analysis platform to help investors weigh opportunities and risks.
FAQs
What is the current price and market cap of BRN.AX stock?
BRN.AX stock is trading at A$0.14 pre-market with a market cap of about A$330,184,159.00. Volume today is 17,169,675.00, above the average of 8,959,143.00.
What does Meyka AI forecast for BRN.AX stock?
Meyka AI’s forecast model projects a yearly price of A$0.166, implying +18.57% versus the current A$0.14. These forecasts are model-based and not guarantees.
What are the main risks for BRN.AX stock investors?
Key risks include negative EPS (-A$0.02), a high price-to-sales ratio (~174.50), execution risk in scaling Akida products, and sensitivity to semiconductor cycle swings and funding sentiment.
When is BrainChip’s next earnings report and why it matters?
BrainChip’s next earnings announcement is scheduled for 04 Mar 2026. That report could shift sentiment if it shows material revenue growth, new design wins, or a clear path to profitability.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)